Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Magainin Pharm (MAGN) -- Ignore unavailable to you. Want to Upgrade?

To: kech who wrote (108)	2/18/1998 11:53:00 PM
From: Shlepper	Read Replies (1) \| Respond to of 233

Tom, I still only hear good things about MAGN. I think everything is on track, and if this is true, then the current price is very low. TRowePrice is buying Magainin in the New Horizons fund. I know I've said it every year for the last 5 years, but I think things are looking good. I'm not sure about insider buying, though. As you said, it may have been exercising options. Insider buying and selling doesn't mean as much to me as it does to others. Most of these biotechs pay management/employees in stock and they sometimes need to pay bills. I wouldn't be surprised if the confidence in the company leads insiders to buy, but I've seen that before and the company didn't always make it. Good to hear from you again! Shep

To: kech who wrote (108)	3/7/1998 8:16:00 AM
From: Volsi Mimir	Respond to of 233

Howdy MAGN : new here.Just passing on some articles about Magainin that I ran across researching this company. Will read the thread and go over finance so I'll stay in the background- They were from "The Medicine Man" weekly article in PR News: talks.com talks.com Since I'm new to the company after you read them , would you comment as to the accuracy of his report (esp on expectation of filing for a New Drug Application of "on the positive results of the two Phase III clinical trials of Cytolex)---meanwhile I'll read the posts here G'Day eddyb